Clarus Securities Weighs in on Aphria Inc’s FY2019 Earnings (APH)

Aphria Inc (TSE:APH) – Research analysts at Clarus Securities raised their FY2019 earnings per share estimates for Aphria in a note issued to investors on Thursday. Clarus Securities analyst N. Atkinson now forecasts that the company will post earnings per share of $0.37 for the year, up from their prior estimate of $0.36.

Aphria (TSE:APH) last announced its quarterly earnings results on Wednesday, January 10th. The company reported C$0.04 earnings per share for the quarter. Aphria had a net margin of 245.74% and a return on equity of 21.38%.

APH has been the subject of several other research reports. Canaccord Genuity raised their price target on shares of Aphria from C$8.25 to C$14.00 in a research report on Tuesday, December 5th. Pi Financial raised their price target on shares of Aphria from C$14.00 to C$25.00 in a research report on Thursday, January 11th.

Shares of Aphria (APH) traded up C$0.40 on Monday, hitting C$22.05. 4,658,900 shares of the company traded hands, compared to its average volume of 5,700,000. The company has a market capitalization of $3,530.00, a P/E ratio of 129.71 and a beta of -1.97. Aphria has a 12 month low of C$4.55 and a 12 month high of C$24.75.

TRADEMARK VIOLATION NOTICE: This piece of content was published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this piece of content on another site, it was stolen and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece of content can be viewed at

Aphria Company Profile

Aphria Inc produces, supplies, and sells medical cannabis in Canada. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It also provides support services in the form of medical consultations, group therapies, and rehabilitation to veteran and first responders.

Earnings History and Estimates for Aphria (TSE:APH)

Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply